|
|
|
NAFLD
https://www.ncbi.nlm.nih.gov/pubmed/28737568
.
Gibson PS1, Lang S, Dhawan A, Fitzpatrick E, Blumfield ML, Truby H, Hart KH, Moore JB. J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):141-149. doi: 10.1097/MPG.0000000000001624.
Abstract
OBJECTIVES:
The aim of the study was to evaluate efficacy of nutrition and physical activity interventions in the clinical management of paediatric nonalcoholic fatty liver disease. The prevalence of paediatric nonalcoholic fatty liver disease continues to rise alongside childhood obesity. Weight loss through lifestyle modification is currently first-line treatment, although supplementation of specific dietary components may be beneficial.
METHODS:
https://pubmed.ncbi.nlm.nih.gov/36042456/ NAFLD
BMC Pediatr. 2022 Aug 30;22(1):511.
doi: 10.1186/s12887-022-03575-w.
The accuracy of fatty liver index for the screening of overweight and obese children for non-alcoholic fatty liver disease in resource limited settings
Mawanane Hewa Aruna Devapriya de Silva 1, Ruwani Punyakanthi Hewawasam 2, Chanika Roshini Kulatunge 3, Rathnayake Mudiyanselage Anjali Chamika 4
Affiliations expand
PMID: 36042456
PMCID: PMC9426280
DOI: 10.1186/s12887-022-03575-w
Free PMC article
Abstract
https://pubmed.ncbi.nlm.nih.gov/37639015/ NAFLD
Review
Eur J Pediatr. 2023 Aug 28.
doi: 10.1007/s00431-023-05169-9.Online ahead of print.
The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials
Nikolaos Gkiourtzis 1, Panagiota Michou 2, Maria Moutafi 3, Agni Glava 3, Konstantinos Cheirakis 3, Aristeidis Christakopoulos 3, Eleni Vouksinou 3, Maria Fotoulaki 3
Abstract
https://pubmed.ncbi.nlm.nih.gov/36675485/ NAFLD
J Clin Med. 2023 Jan 10;12(2):557.
doi: 10.3390/jcm12020557.
The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case-Control Study
Aikaterini Giannouli 1, Vasiliki Efthymiou 1, Marianna Konidari 2, Iliana Mani 3, Leon Aravantinos 4, Spyridon P Dourakis 3, Aristeidis Antoniou 2, Efthymios Deligeoroglou 5, Flora Bacopoulou 1
Abstract
https://pubmed.ncbi.nlm.nih.gov/37497846/ NAFLD
Review
Expert Rev Gastroenterol Hepatol. 2023 Jul 29;1-8.
doi: 10.1080/17474124.2023.2242245. Online ahead of print.
The challenging role of micro-RNAs in non-alcoholic fatty liver disease in children with obesity: is it time for a new era?
Mario Bartiromo 1, Michele Nardolillo 1, Serena Ferrara 1, Giuseppina Russo 1, Emanuele Miraglia Del Giudice 1, Anna Di Sessa 1
Affiliations expand
PMID: 37497846
DOI: 10.1080/17474124.2023.2242245
Abstract
https://pubmed.ncbi.nlm.nih.gov/38081992/ NAFLD
Eur J Pediatr. 2023 Dec 11.
doi: 10.1007/s00431-023-05369-3. Online ahead of print.
The effect of orlistat in the treatment of non-alcoholic fatty liver in adolescents with overweight and obese
Arefeh Zahmatkesh # 1, Mohammad Hassan Sohouli # 2 3, Shima Shojaie 3, Pejman Rohani 4
Abstract
https://pubmed.ncbi.nlm.nih.gov/38682153/ NAFLD
Review
Obes Sci Pract. 2024 Apr 26;10(3):e758.
doi: 10.1002/osp4.758.eCollection 2024 Jun.
The effects of weight loss interventions on children and adolescents with non-alcoholic fatty liver disease: A systematic review and meta-analysis
Mohammad Hassan Sohouli 1 2, Seyedeh Elaheh Bagheri 3, Somaye Fatahi 4, Pejman Rohani 2
Affiliations expand
PMID: 38682153
PMCID: PMC11047132
DOI: 10.1002/osp4.758
Abstract
https://pubmed.ncbi.nlm.nih.gov/38510075/
Front Pediatr. 2024 Mar 6:12:1344714.
doi: 10.3389/fped.2024.1344714. eCollection 2024.
The epidemiological characteristics of liver disease in hospitalized children: a 10-year single-center retrospective study
Fan Chen 1, Yuan Huang 1, Zhihua Huang 1, Feng Fang 1, Hua Zhou 1, Sainan Shu 1
Affiliations expand
PMID: 38510075
PMCID: PMC10950907
DOI: 10.3389/fped.2024.1344714
Abstract
Background: This investigation aimed to examine the epidemiological characteristics of children with liver disease hospitalized for the first time between June 2012 and May 2022 in a tertiary hospital.
https://pubmed.ncbi.nlm.nih.gov/38623942/ NAFLD
J Pediatr Gastroenterol Nutr. 2024 Apr 16.
doi: 10.1002/jpn3.12219. Online ahead of print.
The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults
Brandon J Perumpail 1, Richie Manikat 2, Karn Wijarnpreecha 3 4, George Cholankeril 5 6, Aijaz Ahmed 2, Donghee Kim 2
Affiliations expand
PMID: 38623942
DOI: 10.1002/jpn3.12219
Abstract
Objectives: We investigated the current prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and fibrosis/cirrhosis and identified at-risk populations for MASLD and MASLD-related fibrosis among US adolescents and young adults in the United States.
https://pubmed.ncbi.nlm.nih.gov/37744533/ NAFLD
Review
Iran J Public Health. 2023 Aug;52(8):1600-1612.
doi: 10.18502/ijph.v52i8.13399.
The Prevalence of Non-Alcoholic Fatty Liver Disease in Iranian Children and Adult Population: A Systematic Review and Meta-Analysis
Soheil Hassanipour 1, Ehsan Amini-Salehi 2, Farahnaz Joukar 1 3, Mohammad-Javad Khosousi 1, Farideh Pourtaghi 4, Malek Moein Ansar 5, Marjan Mahdavi-Roshan 6, Forough Heidarzad 1, Golnaz Rashidi-Mojdehi 1, Elham Abdzadeh 1, Azin Vakilpour 7, Fariborz Mansour-Ghanaei 1 3
Abstract
SMS requests to
9224791366
Ask The Expert
Pediatric Liver Specialists in India
Centres offering Genetic Testing for Pediatric Liver Diseases
Financial Aid Offered by Trusts
